Advicenne SA logo

ADVIC - Advicenne SA News Story

€7.08 0.1  1.1%

Last Trade - 3:46pm

Sector
Healthcare
Size
Small Cap
Market Cap £52.9m
Enterprise Value £39.0m
Revenue £1.49m
Position in Universe 558th / 852

BRIEF-Primex Pharmaceuticals Acquires Rights To Ozalin From Advicenne

Thu 13th September, 2018 12:46pm
Sept 13 (Reuters) - PRIMEX PHARMACEUTICALS:
    * ACQUIRES THE RIGHTS TO OZALIN – THE FIRST ORAL PAEDIATRIC
SEDATIVE LICENSED IN THE EU

Source text for Eikon:  ID:nBw9DpL0pa 
Further company coverage:  ADVIC.PA 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.